Login / Signup

Low copper-2 intake in Switzerland does not result in lower incidence of Alzheimer's disease and contradicts the Copper-2 Hypothesis.

Marc Solioz
Published in: Experimental biology and medicine (Maywood, N.J.) (2020)
Keyphrases
  • oxide nanoparticles
  • risk factors
  • cognitive decline